WAKE FOREST UNIVERSITY

Intensive blood pressure management for 3.3 years significantly reduces the risk of mild cognitive impairment and dementia in adults with hypertension.

• A new study suggests GLP-1 receptor agonists and SGLT2 inhibitors may significantly reduce the risk of heart attacks and death in stroke survivors. • SGLT2 inhibitors were associated with a 67% lower risk of second strokes, offering a potential preventative measure for recurrent events. • The research highlights the potential of these diabetes and weight loss drugs in preventing further cardiovascular events in individuals who have experienced ischemic stroke. • Findings indicate a substantial reduction in death rates among stroke survivors taking these medications, from 54% to 11.8%.